Search research articles
Contact Us
Filters
Showing results (221-230 of 287) with videos related to
Page
of 29
Sort By:
Cancer Research Communications
|
October 12, 2023
Concurrent Targeting of HDAC and PI3K to Overcome Phenotypic Heterogeneity of Castration-resistant and Neuroendocrine Prostate Cancers
Ailin Zhang, Nathan A Lau, Alicia Wong, et al.
The Journal of Urology
|
January 18, 2020
Reply by Authors
Jeannette M Schenk, Lisa F Newcomb, Yingye Zheng, et al.
The Journal of Urology
|
October 26, 2019
African American Race is Not Associated with Risk of Reclassification during Active Surveillance: Results from the Canary Prostate Cancer Active Surveillance Study
Jeannette M Schenk, Lisa F Newcomb, Yingye Zheng, et al.
Cancer
|
September 13, 2021
Treatment in the absence of disease reclassification among men on active surveillance for prostate cancer
Peter S Kirk, Kehao Zhu, Yingye Zheng, et al.
The Journal of Urology
|
July 13, 2022
Impact of Prostate Health Index Results for Prediction of Biopsy Grade Reclassification During Active Surveillance
Christopher P Filson, Kehao Zhu, Yijian Huang, et al.
The Prostate
|
March 23, 2021
Targeting backdoor androgen synthesis through AKR1C3 inhibition: A presurgical hormonal ablative neoadjuvant trial in high-risk localized prostate cancer
Laura S Graham, Lawrence D True, Roman Gulati, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 30, 2008
Circulating microRNAs as stable blood-based markers for cancer detection
Patrick S Mitchell, Rachael K Parkin, Evan M Kroh, et al.
The Journal of Urology
|
April 30, 2025
Magnetic Resonance Imaging at Second Surveillance Biopsy After Diagnosis in Patients With Grade Group 1 Prostate Cancer in the Canary Prostate Active Surveillance Study
Meera R Chappidi, Lisa F Newcomb, Yingye Zheng, et al.
JAMA Oncology
|
July 25, 2024
BRCA1, BRCA2, and Associated Cancer Risks and Management for Male Patients: A Review
Heather H Cheng, Jeffrey W Shevach, Elena Castro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 22, 2007
Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy
Andrew J Stephenson, Peter T Scardino, Michael W Kattan, et al.
Page
of 29
Search research articles
Search
Showing results (221-230 of 287) with videos related to
Sort By:
Page
of 29
Cancer Research Communications
|
October 12, 2023
Concurrent Targeting of HDAC and PI3K to Overcome Phenotypic Heterogeneity of Castration-resistant and Neuroendocrine Prostate Cancers
Ailin Zhang, Nathan A Lau, Alicia Wong, et al.
The Journal of Urology
|
January 18, 2020
Reply by Authors
Jeannette M Schenk, Lisa F Newcomb, Yingye Zheng, et al.
The Journal of Urology
|
October 26, 2019
African American Race is Not Associated with Risk of Reclassification during Active Surveillance: Results from the Canary Prostate Cancer Active Surveillance Study
Jeannette M Schenk, Lisa F Newcomb, Yingye Zheng, et al.
Cancer
|
September 13, 2021
Treatment in the absence of disease reclassification among men on active surveillance for prostate cancer
Peter S Kirk, Kehao Zhu, Yingye Zheng, et al.
The Journal of Urology
|
July 13, 2022
Impact of Prostate Health Index Results for Prediction of Biopsy Grade Reclassification During Active Surveillance
Christopher P Filson, Kehao Zhu, Yijian Huang, et al.
The Prostate
|
March 23, 2021
Targeting backdoor androgen synthesis through AKR1C3 inhibition: A presurgical hormonal ablative neoadjuvant trial in high-risk localized prostate cancer
Laura S Graham, Lawrence D True, Roman Gulati, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 30, 2008
Circulating microRNAs as stable blood-based markers for cancer detection
Patrick S Mitchell, Rachael K Parkin, Evan M Kroh, et al.
The Journal of Urology
|
April 30, 2025
Magnetic Resonance Imaging at Second Surveillance Biopsy After Diagnosis in Patients With Grade Group 1 Prostate Cancer in the Canary Prostate Active Surveillance Study
Meera R Chappidi, Lisa F Newcomb, Yingye Zheng, et al.
JAMA Oncology
|
July 25, 2024
BRCA1, BRCA2, and Associated Cancer Risks and Management for Male Patients: A Review
Heather H Cheng, Jeffrey W Shevach, Elena Castro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 22, 2007
Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy
Andrew J Stephenson, Peter T Scardino, Michael W Kattan, et al.
Page
of 29